Sunshine Lake Pharma Signs AI Drug R&D Framework with Shenzhen XtalPi

MT Newswires Live

Jan 27

Sunshine Lake Pharma (HKG:6887) said it has entered into a cooperation framework agreement with Shenzhen XtalPi Technology to pursue a joint venture focused on AI-driven drug research and development, according to a Monday Hong Kong bourse filing.

Shares of the pharmaceutical firm were up over 3% in Tuesday morning trade.

The parties plan to build an AI drug R&D platform, including a joint laboratory for innovative drug discovery, joint development of AI large models across the drug development lifecycle, and the creation of a "Model-as-a-Service" business model, the filing showed.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2606749552"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2606749552\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2606749552?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-27 12:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606749552","market":"hk","top_or_hot":-1,"title":"Sunshine Lake Pharma Signs AI Drug R&D Framework with Shenzhen XtalPi","media":"MT Newswires Live","content":"<html><body><p> Sunshine Lake Pharma (HKG:6887) said it has entered into a cooperation framework agreement with Shenzhen XtalPi Technology to pursue a joint venture focused on AI-driven drug research and development, according to a Monday Hong Kong bourse filing.</p><p>Shares of the pharmaceutical firm were up over 3% in Tuesday morning trade.</p><p>The parties plan to build an AI drug R&amp;D platform, including a joint laboratory for innovative drug discovery, joint development of AI large models across the drug development lifecycle, and the creation of a \"Model-as-a-Service\" business model, the filing showed.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sunshine Lake Pharma Signs AI Drug R&D Framework with Shenzhen XtalPi</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSunshine Lake Pharma Signs AI Drug R&D Framework with Shenzhen XtalPi\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-27 12:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Sunshine Lake Pharma (HKG:6887) said it has entered into a cooperation framework agreement with Shenzhen XtalPi Technology to pursue a joint venture focused on AI-driven drug research and development, according to a Monday Hong Kong bourse filing.</p><p>Shares of the pharmaceutical firm were up over 3% in Tuesday morning trade.</p><p>The parties plan to build an AI drug R&amp;D platform, including a joint laboratory for innovative drug discovery, joint development of AI large models across the drug development lifecycle, and the creation of a \"Model-as-a-Service\" business model, the filing showed.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4543","symbol_name":"AI","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2606749552","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2606749552","pubTimestamp":1769486766,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Sunshine Lake Pharma  said it has entered into a cooperation framework agreement with Shenzhen XtalPi Technology to pursue a joint venture focused on AI-driven drug research and development, according to a Monday Hong Kong bourse filing.Shares of the pharmaceutical firm were up over 3% in Tuesday morning trade.The parties plan to build an AI drug R&D platform, including a joint laboratory for innovative drug discovery, joint development of AI large models across the drug development lifecycle, and the creation of a \"Model-as-a-Service\" business model, the filing showed.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4543":"AI","BK4551":"寇图资本持仓","BK4587":"ChatGPT概念","BK4588":"碎股","BK4528":"SaaS概念","BK1191":"制药","BK4585":"ETF&股票定投概念","BK4023":"应用软件","AI":"C3.ai, Inc.","06887":"东阳光药"},"translate_title":"阳光湖制药与深圳XtalPi签署AI药物研发框架","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06887":1,"AI":0.66},"content_text":"Sunshine Lake Pharma (HKG:6887) said it has entered into a cooperation framework agreement with Shenzhen XtalPi Technology to pursue a joint venture focused on AI-driven drug research and development, according to a Monday Hong Kong bourse filing.Shares of the pharmaceutical firm were up over 3% in Tuesday morning trade.The parties plan to build an AI drug R&D platform, including a joint laboratory for innovative drug discovery, joint development of AI large models across the drug development lifecycle, and the creation of a \"Model-as-a-Service\" business model, the filing showed.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}